Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 402 followers

Latest posts

Last updated 13 minutes ago

CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike

13 minutes ago

The company chalks up a finanical impact of about 150 billion Korean...

After March cuts, Novartis trims another 60 roles at US headquarters

33 minutes ago

After submitting plans to cut 114 jobs tied to its U.S. headquarters...

Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger

about 2 hours ago

Bristol Myers Squibb is warming up for the FIFA World Cup 2026...

Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion

about 3 hours ago

After topping up its long-running operations in Puerto Rico last year, Amgen...

GLP-1 boom pushes oncology off top spot for late-stage pipeline value: Deloitte

about 5 hours ago

For the first time in its 16-year analysis of the pharma industry...

Rising Stars: Axplora’s Arsalan Khan gets technical on marketing

about 9 hours ago

Rising Stars: A strategic marketing lead at CDMO Axplora, Arsalan Khan is...

FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype

3 days ago

The early FDA approval doesn't change Pfizer and Arvinas' plan to leave...

Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation

3 days ago

Four years after gaining FDA approval for Auvelity to treat major depressive...

Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed

3 days ago

Shortly after laying out $75 million upfront for Corstasis Therapeutics and its...

Union workers at Korean CDMO Samsung Biologics kick off strike

3 days ago

The company looks to achieve an "amicable resolution as soon as possible"...

Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble

3 days ago

A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 trial has...

FDA expectations create potential friction in new Form 483 response guidance

3 days ago

Looking to clarify its expectations on manufacturer responses following inspections, the FDA...